Evercore Wealth Management, LLC Biogen Inc. Transaction History

Evercore Wealth Management, LLC

$6.35 Billion
Q2 2024

A detailed history of Evercore Wealth Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 2,142 shares of BIIB stock, worth $432,255. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,142

Previous 2,142 -0.0%

Holding current value

$432,255

Previous $461,000 7.59%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $1,696 - $2,141	-8 Reduced 0.37%	2,142 $461,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $2,225 - $2,679	-10 Reduced 0.46%	2,150 $556,000
Q2 2023 Aug 04, 2023	SELL	$275.25 - $318.06 $825 - $954	-3 Reduced 0.14%	2,160 $615,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $3,335 - $3,800	13 Added 0.6%	2,163 $601,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $25,244 - $30,672	-100 Reduced 4.44%	2,150 $595,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $5,038 - $6,347	-26 Reduced 1.14%	2,250 $474,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $299,157 - $384,460	-1,336 Reduced 36.99%	2,276 $546,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $282,424 - $368,311	-998 Reduced 21.65%	3,612 $1.02 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $27,713 - $44,373	-107 Reduced 2.27%	4,610 $1.6 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $7,045 - $8,254	29 Added 0.62%	4,717 $1.32 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $118,366 - $178,170	-501 Reduced 9.66%	4,688 $1.15 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $31,242 - $36,073	-118 Reduced 2.22%	5,189 $1.47 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $8,018 - $10,619	-31 Reduced 0.58%	5,307 $1.42 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $76,622 - $97,196	-285 Reduced 5.07%	5,338 $1.69 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $44,012 - $60,814	-200 Reduced 3.43%	5,623 $1.67 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $24,353 - $27,314	112 Added 1.96%	5,823 $1.36 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $22,367 - $24,655	-102 Reduced 1.75%	5,711 $1.34 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $64,796 - $101,349	-299 Reduced 4.89%	5,813 $1.37 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $38,154 - $48,326	137 Added 2.29%	6,112 $1.84 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $138,243 - $180,783	-471 Reduced 7.31%	5,975 $2.11 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $572,982 - $682,874	2,225 Added 52.71%	6,446 $1.87 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $39,019 - $55,186	-150 Reduced 3.43%	4,221 $1.16 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $179,354 - $200,890	-583 Reduced 11.77%	4,371 $1.39 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $1.39 Million - $1.63 Million	4,954	4,954 $1.55 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $29.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.

Account

Evercore Wealth Management, LLC Biogen Inc. Transaction History